Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-28

Clinical Trial Update: Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing the benefits of morphine gel in reducing pain for cancer-related wounds.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine Gel (morphine)

Snippet

Sponsor: Instituto Nacional de Cancer, Brazil | Conditions: Wounds and Injuries, Cancer Pain | Phase 2 | Status: UNKNOWN